Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands

We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% preva...

Full description

Bibliographic Details
Published in:Emerging Infectious Diseases
Main Authors: Petersen, Maria Skaalum, Strøm, Marin, Christiansen, Debes Hammershaimb, Fjallsbak, Jógvan Páll, Eliasen, Eina Hansen, Johansen, Malan, Veyhe, Anna Sofía, Kristiansen, Marnar Fríðheim, Gaini, Shahin, Møller, Lars Fodgaard, Steig, Bjarni, Weihe, Pál
Format: Text
Language:English
Published: Centers for Disease Control and Prevention 2020
Subjects:
Research Letter
Faroe Islands
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588539/
http://www.ncbi.nlm.nih.gov/pubmed/32726200
https://doi.org/10.3201/eid2611.202736
Description
Summary:We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% prevalence. Our findings will help us evaluate our public health response.

Similar Items